Menu

Resources

Displaying 1 - 10 of 10 results.

WHO: Lassa fever research and development (R&D) roadmap

This resource provides a framework for identifying the vision, underpinning strategic goals, and prioritizing areas and activities for accelerating the collaborative development of medical countermeasures.

Read more
Learn more about this resource.

Lessons from the West Africa Ebola epidemic: A systematic review of epidemiological and social and behavioral science research priorities

This systematic literature review compared the epidemiological (EPI) research and the qualitative social and behavioral science (SBS) research published during the West Africa Ebola virus disease (EVD) epidemic. The findings support a program of action that situates data collection and analysis in real-time, recursive, integrated efforts to move community attitudes, behaviors, and responses into epidemiological research, and the paper offers recommendations to improve coordinated, multidisciplinary approaches to health emergencies.

Read more
Learn more about this resource.

Ebola: Limitations of correcting misinformation

In this resource, members of the Ebola Response Anthropology Platform call on all organisations involved in the response to the Ebola outbreak to question the assumption that biomedicine must correct local logics and concerns, and the effectiveness of using standardised advice for non-standardised situations.

Read more
Learn more about this resource.

New opportunities for field research on the pathogenesis and treatment of Lassa fever

This resource reviews the present literature on treatment and pathogenesis of Lassa fever and outlines priorities for future research in the field made possible by the improved research capacity of the Mano River Union countries of Sierra Leone, Liberia, and Guinea, Lassa fever network. 

Read more
Learn more about this resource.

Engaging ‘communities’: Anthropological insights from the West African Ebola epidemic

This resource reflects on the nature of community engagement during the Ebola epidemic and demonstrates a disjuncture between local realities and what is being imagined in post-Ebola reports about the lessons that need to be learned for the future. It argues that to achieve stated aims of building trust and strengthening outbreak response and health systems, public health institutions need to reorientate their conceptualization of ‘the community’ and develop ways of working which take complex social and political relationships into account.

Read more
Learn more about this resource.

U.S. Centre for Disease Control (CDC): Lassa fever

Further information from the U.S. CDC in both English and French about the transmission, prevention, diagnosis and treatment of Lassa fever.

Read more
Learn more about this resource.

U.S Centre for Disease Control (CDC): Ebola hemorrhagic fever information packet

This resource provides a fact sheet for Ebola as well as a case count and location list for April 9th, 2010.

Read more
Learn more about this resource.

Safe intensive-care management of a severe case of Lassa fever with simple barrier nursing techniques

This resource describes the case-management of Lassa fever in a specific patient and the difficulties encountered in repatriating her for diagnosis and management, which is unavailable in Sierra Leone, are described.The experience with this case has implications for the medical care and safe handling of Lassa fever in both endemic and nonendemic areas.

Read more
Learn more about this resource.

Lassa fever: Epidemiology, clinical features, and social consequences

This resource describes the epidemiology of Lassa fever and its vector, as well as the clinical course and management of the disease. It then reports on current treatment efforts, surveillance and disease control before presenting community perspectives through a knowledge, attitude and practice survey and a qualitative study.  

Read more
Learn more about this resource.

Lassa fever

In a study of Lassa fever in Sierra Leone, West Africa, this paper identifies two variables associated with a high risk of death, and evaluates the efficacy of ribavirin and Lassa virus–convalescent plasma for the treatment of Lassa fever.

Read more
Learn more about this resource.
Subscribe to Resources